# Efficacy and Safety of a Purified Standardised Bee Venom Preparation

> **NCT00263952** · PHASE3 · COMPLETED · sponsor: **Allergopharma GmbH & Co. KG**

## Conditions studied

- Bee Venom Allergy

## Interventions

- **BIOLOGICAL:** bee venom

## Key facts

- **NCT ID:** NCT00263952
- **Lead sponsor:** Allergopharma GmbH & Co. KG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** 2005-01
- **Final completion:** 2010-04
- **Target enrollment:** — (—)
- **Last updated:** 2013-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00263952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00263952, "Efficacy and Safety of a Purified Standardised Bee Venom Preparation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00263952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*